Insulin Pricing MDL Sought By 5 States For Drug Makers, PBMs
WASHINGTON, D.C. — Five states have asked the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize five federal lawsuits alleging that the three largest manufacturers of insulin and the three largest...To view the full article, register now.
Already a subscriber? Click here to view full article